Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$14.7 - $28.67 $13.2 Million - $25.7 Million
-897,264 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$24.31 - $33.6 $604,346 - $835,296
-24,860 Reduced 2.7%
897,264 $25.5 Million
Q2 2021

Aug 12, 2021

BUY
$26.09 - $40.4 $213,859 - $331,158
8,197 Added 0.9%
922,124 $31.1 Million
Q1 2021

May 11, 2021

BUY
$33.06 - $56.93 $508,495 - $875,640
15,381 Added 1.71%
913,927 $34.9 Million
Q4 2020

Feb 10, 2021

BUY
$39.09 - $57.4 $905,558 - $1.33 Million
23,166 Added 2.65%
898,546 $37.6 Million
Q3 2020

Nov 12, 2020

BUY
$28.43 - $44.67 $24.9 Million - $39.1 Million
875,380 New
875,380 $37.9 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.